Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.12 USD | +5.41% | +11.65% | +28.93% |
Evolution of the average Target Price on Anebulo Pharmaceuticals, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Anebulo Pharmaceuticals, Inc.
Maxim | |
HC Wainwright | |
Benchmark Company | |
Ladenburg Thalmann | |
Benchmark Capital |
EPS Revisions
- Stock Market
- Equities
- ANEB Stock
- Consensus Anebulo Pharmaceuticals, Inc.